Fibrinogen-Binding Peptide |
| Catalog No.GC66420 |
Le peptide de liaison au fibrinogène (conÇu par l'hypothèse d'anticomplémentarité) est un peptide mimétique présumé du site de liaison de la vitronectine sur le récepteur du fibrinogène. Le peptide de liaison au fibrinogène lie le fibrinogène et inhibe À la fois l'adhésion des plaquettes au fibrinogène et l'agrégation plaquettaire, et inhibe également l'adhésion des plaquettes À la vitronectine.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 137235-80-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1].
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *